nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—CYP1A2—Pentoxifylline—systemic scleroderma	0.134	0.32	CbGbCtD
Rotigotine—CYP1A2—Leflunomide—systemic scleroderma	0.128	0.305	CbGbCtD
Rotigotine—CYP2D6—Captopril—systemic scleroderma	0.0828	0.197	CbGbCtD
Rotigotine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0415	0.0988	CbGbCtD
Rotigotine—CYP3A4—Prednisone—systemic scleroderma	0.0331	0.0789	CbGbCtD
Rotigotine—Hypotension—Leflunomide—systemic scleroderma	0.000952	0.00164	CcSEcCtD
Rotigotine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000946	0.00163	CcSEcCtD
Rotigotine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000944	0.00163	CcSEcCtD
Rotigotine—Loss of consciousness—Lisinopril—systemic scleroderma	0.000943	0.00162	CcSEcCtD
Rotigotine—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00094	0.00162	CcSEcCtD
Rotigotine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000939	0.00162	CcSEcCtD
Rotigotine—Cough—Lisinopril—systemic scleroderma	0.000936	0.00161	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000931	0.00161	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000928	0.0016	CcSEcCtD
Rotigotine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000926	0.0016	CcSEcCtD
Rotigotine—Insomnia—Leflunomide—systemic scleroderma	0.000921	0.00159	CcSEcCtD
Rotigotine—Paraesthesia—Leflunomide—systemic scleroderma	0.000915	0.00158	CcSEcCtD
Rotigotine—Arthralgia—Lisinopril—systemic scleroderma	0.000913	0.00157	CcSEcCtD
Rotigotine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000908	0.00157	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000907	0.00156	CcSEcCtD
Rotigotine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000903	0.00156	CcSEcCtD
Rotigotine—Discomfort—Lisinopril—systemic scleroderma	0.000902	0.00156	CcSEcCtD
Rotigotine—Lethargy—Methotrexate—systemic scleroderma	0.000902	0.00155	CcSEcCtD
Rotigotine—Dyspepsia—Leflunomide—systemic scleroderma	0.000897	0.00155	CcSEcCtD
Rotigotine—Vomiting—Mometasone—systemic scleroderma	0.000895	0.00154	CcSEcCtD
Rotigotine—Dry mouth—Lisinopril—systemic scleroderma	0.000893	0.00154	CcSEcCtD
Rotigotine—Sweating increased—Prednisone—systemic scleroderma	0.00089	0.00153	CcSEcCtD
Rotigotine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000889	0.00153	CcSEcCtD
Rotigotine—Rash—Mometasone—systemic scleroderma	0.000887	0.00153	CcSEcCtD
Rotigotine—Asthenia—Captopril—systemic scleroderma	0.000887	0.00153	CcSEcCtD
Rotigotine—Dermatitis—Mometasone—systemic scleroderma	0.000886	0.00153	CcSEcCtD
Rotigotine—Decreased appetite—Leflunomide—systemic scleroderma	0.000886	0.00153	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000885	0.00153	CcSEcCtD
Rotigotine—Confusional state—Lisinopril—systemic scleroderma	0.000883	0.00152	CcSEcCtD
Rotigotine—Headache—Mometasone—systemic scleroderma	0.000882	0.00152	CcSEcCtD
Rotigotine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00088	0.00152	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000879	0.00152	CcSEcCtD
Rotigotine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000879	0.00152	CcSEcCtD
Rotigotine—Fatigue—Leflunomide—systemic scleroderma	0.000878	0.00151	CcSEcCtD
Rotigotine—Pruritus—Captopril—systemic scleroderma	0.000874	0.00151	CcSEcCtD
Rotigotine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000873	0.0015	CcSEcCtD
Rotigotine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000872	0.0015	CcSEcCtD
Rotigotine—Pain—Leflunomide—systemic scleroderma	0.000871	0.0015	CcSEcCtD
Rotigotine—Constipation—Leflunomide—systemic scleroderma	0.000871	0.0015	CcSEcCtD
Rotigotine—Infection—Lisinopril—systemic scleroderma	0.00087	0.0015	CcSEcCtD
Rotigotine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000864	0.00149	CcSEcCtD
Rotigotine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000864	0.00149	CcSEcCtD
Rotigotine—Shock—Lisinopril—systemic scleroderma	0.000861	0.00148	CcSEcCtD
Rotigotine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000859	0.00148	CcSEcCtD
Rotigotine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000855	0.00147	CcSEcCtD
Rotigotine—Skin disorder—Lisinopril—systemic scleroderma	0.00085	0.00147	CcSEcCtD
Rotigotine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000847	0.00146	CcSEcCtD
Rotigotine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000846	0.00146	CcSEcCtD
Rotigotine—Diarrhoea—Captopril—systemic scleroderma	0.000846	0.00146	CcSEcCtD
Rotigotine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000845	0.00146	CcSEcCtD
Rotigotine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000844	0.00146	CcSEcCtD
Rotigotine—Irritability—Methotrexate—systemic scleroderma	0.000844	0.00145	CcSEcCtD
Rotigotine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000843	0.00145	CcSEcCtD
Rotigotine—Erectile dysfunction—Prednisone—systemic scleroderma	0.000842	0.00145	CcSEcCtD
Rotigotine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000839	0.00145	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000839	0.00145	CcSEcCtD
Rotigotine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000838	0.00144	CcSEcCtD
Rotigotine—Nausea—Mometasone—systemic scleroderma	0.000836	0.00144	CcSEcCtD
Rotigotine—Anorexia—Lisinopril—systemic scleroderma	0.000834	0.00144	CcSEcCtD
Rotigotine—Weight increased—Prednisone—systemic scleroderma	0.000832	0.00143	CcSEcCtD
Rotigotine—Pain—Mycophenolic acid—systemic scleroderma	0.000831	0.00143	CcSEcCtD
Rotigotine—Constipation—Mycophenolic acid—systemic scleroderma	0.000831	0.00143	CcSEcCtD
Rotigotine—Weight decreased—Prednisone—systemic scleroderma	0.000827	0.00143	CcSEcCtD
Rotigotine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000826	0.00142	CcSEcCtD
Rotigotine—Cough—Mycophenolate mofetil—systemic scleroderma	0.00082	0.00141	CcSEcCtD
Rotigotine—Hypotension—Lisinopril—systemic scleroderma	0.000818	0.00141	CcSEcCtD
Rotigotine—Dizziness—Captopril—systemic scleroderma	0.000817	0.00141	CcSEcCtD
Rotigotine—Depression—Prednisone—systemic scleroderma	0.000813	0.0014	CcSEcCtD
Rotigotine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000811	0.0014	CcSEcCtD
Rotigotine—Urticaria—Leflunomide—systemic scleroderma	0.000809	0.00139	CcSEcCtD
Rotigotine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000801	0.00138	CcSEcCtD
Rotigotine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.0008	0.00138	CcSEcCtD
Rotigotine—Breast disorder—Methotrexate—systemic scleroderma	0.000799	0.00138	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000797	0.00137	CcSEcCtD
Rotigotine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000795	0.00137	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000795	0.00137	CcSEcCtD
Rotigotine—Insomnia—Lisinopril—systemic scleroderma	0.000792	0.00136	CcSEcCtD
Rotigotine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00079	0.00136	CcSEcCtD
Rotigotine—Paraesthesia—Lisinopril—systemic scleroderma	0.000786	0.00135	CcSEcCtD
Rotigotine—Vomiting—Captopril—systemic scleroderma	0.000786	0.00135	CcSEcCtD
Rotigotine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000782	0.00135	CcSEcCtD
Rotigotine—Rash—Captopril—systemic scleroderma	0.000779	0.00134	CcSEcCtD
Rotigotine—Dermatitis—Captopril—systemic scleroderma	0.000779	0.00134	CcSEcCtD
Rotigotine—Somnolence—Lisinopril—systemic scleroderma	0.000778	0.00134	CcSEcCtD
Rotigotine—Headache—Captopril—systemic scleroderma	0.000774	0.00133	CcSEcCtD
Rotigotine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000773	0.00133	CcSEcCtD
Rotigotine—Dyspepsia—Lisinopril—systemic scleroderma	0.00077	0.00133	CcSEcCtD
Rotigotine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000762	0.00131	CcSEcCtD
Rotigotine—Decreased appetite—Lisinopril—systemic scleroderma	0.000761	0.00131	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000756	0.0013	CcSEcCtD
Rotigotine—Fatigue—Lisinopril—systemic scleroderma	0.000755	0.0013	CcSEcCtD
Rotigotine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000755	0.0013	CcSEcCtD
Rotigotine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000752	0.0013	CcSEcCtD
Rotigotine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000751	0.00129	CcSEcCtD
Rotigotine—Pain—Lisinopril—systemic scleroderma	0.000749	0.00129	CcSEcCtD
Rotigotine—Constipation—Lisinopril—systemic scleroderma	0.000749	0.00129	CcSEcCtD
Rotigotine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000745	0.00128	CcSEcCtD
Rotigotine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000741	0.00128	CcSEcCtD
Rotigotine—Diarrhoea—Azathioprine—systemic scleroderma	0.000738	0.00127	CcSEcCtD
Rotigotine—Nausea—Captopril—systemic scleroderma	0.000734	0.00127	CcSEcCtD
Rotigotine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000731	0.00126	CcSEcCtD
Rotigotine—Asthenia—Leflunomide—systemic scleroderma	0.000731	0.00126	CcSEcCtD
Rotigotine—Hallucination—Prednisone—systemic scleroderma	0.000728	0.00125	CcSEcCtD
Rotigotine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000721	0.00124	CcSEcCtD
Rotigotine—Pruritus—Leflunomide—systemic scleroderma	0.000721	0.00124	CcSEcCtD
Rotigotine—Connective tissue disorder—Prednisone—systemic scleroderma	0.000719	0.00124	CcSEcCtD
Rotigotine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000717	0.00124	CcSEcCtD
Rotigotine—Dizziness—Azathioprine—systemic scleroderma	0.000713	0.00123	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.00071	0.00122	CcSEcCtD
Rotigotine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000704	0.00121	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000699	0.0012	CcSEcCtD
Rotigotine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000697	0.0012	CcSEcCtD
Rotigotine—Diarrhoea—Leflunomide—systemic scleroderma	0.000697	0.0012	CcSEcCtD
Rotigotine—Urticaria—Lisinopril—systemic scleroderma	0.000695	0.0012	CcSEcCtD
Rotigotine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000694	0.0012	CcSEcCtD
Rotigotine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000689	0.00119	CcSEcCtD
Rotigotine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000688	0.00119	CcSEcCtD
Rotigotine—Vomiting—Azathioprine—systemic scleroderma	0.000686	0.00118	CcSEcCtD
Rotigotine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000682	0.00118	CcSEcCtD
Rotigotine—Infestation NOS—Methotrexate—systemic scleroderma	0.000681	0.00117	CcSEcCtD
Rotigotine—Infestation—Methotrexate—systemic scleroderma	0.000681	0.00117	CcSEcCtD
Rotigotine—Rash—Azathioprine—systemic scleroderma	0.00068	0.00117	CcSEcCtD
Rotigotine—Dermatitis—Azathioprine—systemic scleroderma	0.000679	0.00117	CcSEcCtD
Rotigotine—Depression—Methotrexate—systemic scleroderma	0.000679	0.00117	CcSEcCtD
Rotigotine—Headache—Azathioprine—systemic scleroderma	0.000676	0.00116	CcSEcCtD
Rotigotine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000675	0.00116	CcSEcCtD
Rotigotine—Dizziness—Leflunomide—systemic scleroderma	0.000674	0.00116	CcSEcCtD
Rotigotine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000667	0.00115	CcSEcCtD
Rotigotine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000665	0.00115	CcSEcCtD
Rotigotine—Angiopathy—Prednisone—systemic scleroderma	0.000664	0.00114	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000662	0.00114	CcSEcCtD
Rotigotine—Immune system disorder—Prednisone—systemic scleroderma	0.000661	0.00114	CcSEcCtD
Rotigotine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000656	0.00113	CcSEcCtD
Rotigotine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000656	0.00113	CcSEcCtD
Rotigotine—Vomiting—Leflunomide—systemic scleroderma	0.000648	0.00112	CcSEcCtD
Rotigotine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000645	0.00111	CcSEcCtD
Rotigotine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000643	0.00111	CcSEcCtD
Rotigotine—Rash—Leflunomide—systemic scleroderma	0.000642	0.00111	CcSEcCtD
Rotigotine—Dermatitis—Leflunomide—systemic scleroderma	0.000642	0.00111	CcSEcCtD
Rotigotine—Mental disorder—Prednisone—systemic scleroderma	0.000641	0.00111	CcSEcCtD
Rotigotine—Nausea—Azathioprine—systemic scleroderma	0.000641	0.0011	CcSEcCtD
Rotigotine—Headache—Leflunomide—systemic scleroderma	0.000638	0.0011	CcSEcCtD
Rotigotine—Erythema—Prednisone—systemic scleroderma	0.000637	0.0011	CcSEcCtD
Rotigotine—Malnutrition—Prednisone—systemic scleroderma	0.000637	0.0011	CcSEcCtD
Rotigotine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000632	0.00109	CcSEcCtD
Rotigotine—Asthenia—Lisinopril—systemic scleroderma	0.000628	0.00108	CcSEcCtD
Rotigotine—Pruritus—Lisinopril—systemic scleroderma	0.000619	0.00107	CcSEcCtD
Rotigotine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000618	0.00107	CcSEcCtD
Rotigotine—Rash—Mycophenolic acid—systemic scleroderma	0.000613	0.00106	CcSEcCtD
Rotigotine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000612	0.00106	CcSEcCtD
Rotigotine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000609	0.00105	CcSEcCtD
Rotigotine—Headache—Mycophenolic acid—systemic scleroderma	0.000609	0.00105	CcSEcCtD
Rotigotine—Nausea—Leflunomide—systemic scleroderma	0.000605	0.00104	CcSEcCtD
Rotigotine—Diarrhoea—Lisinopril—systemic scleroderma	0.000599	0.00103	CcSEcCtD
Rotigotine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000591	0.00102	CcSEcCtD
Rotigotine—Visual impairment—Methotrexate—systemic scleroderma	0.000589	0.00102	CcSEcCtD
Rotigotine—Agitation—Prednisone—systemic scleroderma	0.000585	0.00101	CcSEcCtD
Rotigotine—Angioedema—Prednisone—systemic scleroderma	0.000582	0.001	CcSEcCtD
Rotigotine—Dizziness—Lisinopril—systemic scleroderma	0.000579	0.000998	CcSEcCtD
Rotigotine—Nausea—Mycophenolic acid—systemic scleroderma	0.000577	0.000995	CcSEcCtD
Rotigotine—Malaise—Prednisone—systemic scleroderma	0.000574	0.00099	CcSEcCtD
Rotigotine—Vertigo—Prednisone—systemic scleroderma	0.000572	0.000986	CcSEcCtD
Rotigotine—Syncope—Prednisone—systemic scleroderma	0.000571	0.000985	CcSEcCtD
Rotigotine—Tinnitus—Methotrexate—systemic scleroderma	0.00057	0.000983	CcSEcCtD
Rotigotine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000565	0.000974	CcSEcCtD
Rotigotine—Loss of consciousness—Prednisone—systemic scleroderma	0.00056	0.000965	CcSEcCtD
Rotigotine—Vomiting—Lisinopril—systemic scleroderma	0.000557	0.000959	CcSEcCtD
Rotigotine—Angiopathy—Methotrexate—systemic scleroderma	0.000555	0.000956	CcSEcCtD
Rotigotine—Immune system disorder—Methotrexate—systemic scleroderma	0.000552	0.000952	CcSEcCtD
Rotigotine—Rash—Lisinopril—systemic scleroderma	0.000552	0.000951	CcSEcCtD
Rotigotine—Dermatitis—Lisinopril—systemic scleroderma	0.000551	0.00095	CcSEcCtD
Rotigotine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000551	0.00095	CcSEcCtD
Rotigotine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00055	0.000948	CcSEcCtD
Rotigotine—Hypertension—Prednisone—systemic scleroderma	0.00055	0.000948	CcSEcCtD
Rotigotine—Headache—Lisinopril—systemic scleroderma	0.000548	0.000945	CcSEcCtD
Rotigotine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000543	0.000935	CcSEcCtD
Rotigotine—Arthralgia—Prednisone—systemic scleroderma	0.000542	0.000935	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000539	0.000928	CcSEcCtD
Rotigotine—Discomfort—Prednisone—systemic scleroderma	0.000536	0.000924	CcSEcCtD
Rotigotine—Mental disorder—Methotrexate—systemic scleroderma	0.000536	0.000923	CcSEcCtD
Rotigotine—Erythema—Methotrexate—systemic scleroderma	0.000532	0.000918	CcSEcCtD
Rotigotine—Malnutrition—Methotrexate—systemic scleroderma	0.000532	0.000918	CcSEcCtD
Rotigotine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000525	0.000905	CcSEcCtD
Rotigotine—Nausea—Lisinopril—systemic scleroderma	0.00052	0.000896	CcSEcCtD
Rotigotine—Infection—Prednisone—systemic scleroderma	0.000516	0.00089	CcSEcCtD
Rotigotine—Shock—Prednisone—systemic scleroderma	0.000511	0.000882	CcSEcCtD
Rotigotine—Nervous system disorder—Prednisone—systemic scleroderma	0.00051	0.000879	CcSEcCtD
Rotigotine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000507	0.000874	CcSEcCtD
Rotigotine—Skin disorder—Prednisone—systemic scleroderma	0.000505	0.00087	CcSEcCtD
Rotigotine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000503	0.000866	CcSEcCtD
Rotigotine—Anorexia—Prednisone—systemic scleroderma	0.000496	0.000854	CcSEcCtD
Rotigotine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000494	0.000851	CcSEcCtD
Rotigotine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000488	0.000841	CcSEcCtD
Rotigotine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000484	0.000834	CcSEcCtD
Rotigotine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000483	0.000833	CcSEcCtD
Rotigotine—Headache—Mycophenolate mofetil—systemic scleroderma	0.00048	0.000828	CcSEcCtD
Rotigotine—Malaise—Methotrexate—systemic scleroderma	0.00048	0.000827	CcSEcCtD
Rotigotine—Vertigo—Methotrexate—systemic scleroderma	0.000478	0.000824	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000474	0.000816	CcSEcCtD
Rotigotine—Insomnia—Prednisone—systemic scleroderma	0.00047	0.00081	CcSEcCtD
Rotigotine—Paraesthesia—Prednisone—systemic scleroderma	0.000467	0.000805	CcSEcCtD
Rotigotine—Cough—Methotrexate—systemic scleroderma	0.000465	0.000801	CcSEcCtD
Rotigotine—Dyspepsia—Prednisone—systemic scleroderma	0.000458	0.000789	CcSEcCtD
Rotigotine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000456	0.000785	CcSEcCtD
Rotigotine—Arthralgia—Methotrexate—systemic scleroderma	0.000453	0.000781	CcSEcCtD
Rotigotine—Decreased appetite—Prednisone—systemic scleroderma	0.000452	0.000779	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.00045	0.000776	CcSEcCtD
Rotigotine—Fatigue—Prednisone—systemic scleroderma	0.000448	0.000773	CcSEcCtD
Rotigotine—Discomfort—Methotrexate—systemic scleroderma	0.000448	0.000772	CcSEcCtD
Rotigotine—Constipation—Prednisone—systemic scleroderma	0.000445	0.000766	CcSEcCtD
Rotigotine—Confusional state—Methotrexate—systemic scleroderma	0.000438	0.000755	CcSEcCtD
Rotigotine—Infection—Methotrexate—systemic scleroderma	0.000432	0.000744	CcSEcCtD
Rotigotine—Feeling abnormal—Prednisone—systemic scleroderma	0.000428	0.000738	CcSEcCtD
Rotigotine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000426	0.000734	CcSEcCtD
Rotigotine—Skin disorder—Methotrexate—systemic scleroderma	0.000422	0.000727	CcSEcCtD
Rotigotine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00042	0.000724	CcSEcCtD
Rotigotine—Anorexia—Methotrexate—systemic scleroderma	0.000414	0.000714	CcSEcCtD
Rotigotine—Urticaria—Prednisone—systemic scleroderma	0.000413	0.000712	CcSEcCtD
Rotigotine—Hypotension—Methotrexate—systemic scleroderma	0.000406	0.0007	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000396	0.000682	CcSEcCtD
Rotigotine—Insomnia—Methotrexate—systemic scleroderma	0.000393	0.000677	CcSEcCtD
Rotigotine—Paraesthesia—Methotrexate—systemic scleroderma	0.00039	0.000672	CcSEcCtD
Rotigotine—Somnolence—Methotrexate—systemic scleroderma	0.000386	0.000666	CcSEcCtD
Rotigotine—Hypersensitivity—Prednisone—systemic scleroderma	0.000383	0.00066	CcSEcCtD
Rotigotine—Dyspepsia—Methotrexate—systemic scleroderma	0.000382	0.000659	CcSEcCtD
Rotigotine—Decreased appetite—Methotrexate—systemic scleroderma	0.000378	0.000651	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000375	0.000647	CcSEcCtD
Rotigotine—Fatigue—Methotrexate—systemic scleroderma	0.000375	0.000646	CcSEcCtD
Rotigotine—Asthenia—Prednisone—systemic scleroderma	0.000373	0.000643	CcSEcCtD
Rotigotine—Pain—Methotrexate—systemic scleroderma	0.000372	0.00064	CcSEcCtD
Rotigotine—Pruritus—Prednisone—systemic scleroderma	0.000368	0.000634	CcSEcCtD
Rotigotine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000358	0.000617	CcSEcCtD
Rotigotine—Diarrhoea—Prednisone—systemic scleroderma	0.000356	0.000613	CcSEcCtD
Rotigotine—Urticaria—Methotrexate—systemic scleroderma	0.000345	0.000595	CcSEcCtD
Rotigotine—Dizziness—Prednisone—systemic scleroderma	0.000344	0.000593	CcSEcCtD
Rotigotine—Vomiting—Prednisone—systemic scleroderma	0.000331	0.00057	CcSEcCtD
Rotigotine—Rash—Prednisone—systemic scleroderma	0.000328	0.000565	CcSEcCtD
Rotigotine—Dermatitis—Prednisone—systemic scleroderma	0.000327	0.000564	CcSEcCtD
Rotigotine—Headache—Prednisone—systemic scleroderma	0.000326	0.000561	CcSEcCtD
Rotigotine—Hypersensitivity—Methotrexate—systemic scleroderma	0.00032	0.000552	CcSEcCtD
Rotigotine—Asthenia—Methotrexate—systemic scleroderma	0.000312	0.000537	CcSEcCtD
Rotigotine—Nausea—Prednisone—systemic scleroderma	0.000309	0.000532	CcSEcCtD
Rotigotine—Pruritus—Methotrexate—systemic scleroderma	0.000307	0.00053	CcSEcCtD
Rotigotine—Diarrhoea—Methotrexate—systemic scleroderma	0.000297	0.000512	CcSEcCtD
Rotigotine—Dizziness—Methotrexate—systemic scleroderma	0.000287	0.000495	CcSEcCtD
Rotigotine—Vomiting—Methotrexate—systemic scleroderma	0.000276	0.000476	CcSEcCtD
Rotigotine—Rash—Methotrexate—systemic scleroderma	0.000274	0.000472	CcSEcCtD
Rotigotine—Dermatitis—Methotrexate—systemic scleroderma	0.000274	0.000472	CcSEcCtD
Rotigotine—Headache—Methotrexate—systemic scleroderma	0.000272	0.000469	CcSEcCtD
Rotigotine—Nausea—Methotrexate—systemic scleroderma	0.000258	0.000445	CcSEcCtD
